Camtek Ltd. Files 6-K Report
Ticker: CAMT · Form: 6-K · Filed: Aug 15, 2024 · CIK: 1109138
| Field | Detail |
|---|---|
| Company | Camtek Ltd (CAMT) |
| Form Type | 6-K |
| Filed Date | Aug 15, 2024 |
| Risk Level | low |
| Pages | 17 |
| Reading Time | 20 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer
TL;DR
Camtek Ltd. filed a 6-K, confirming 20-F annual reports. Standard update.
AI Summary
Camtek Ltd. filed a Form 6-K on August 15, 2024, reporting as a foreign private issuer. The filing provides information for the month of August 2024 and confirms that Camtek Ltd. files annual reports under Form 20-F. The company is located in Migdal Haemek, Israel, and operates in the optical instruments & lenses sector.
Why It Matters
This filing serves as an update for investors and the market regarding Camtek Ltd.'s regulatory reporting status as a foreign private issuer.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (6-K) that does not contain new financial or operational information that would typically impact risk.
Key Players & Entities
- CAMTEK LTD (company) — Registrant
- August 2024 (date) — Reporting period
- 20240815 (date) — Filing date
- Migdal Haemek, Israel (location) — Company headquarters
FAQ
What type of filing is this?
This is a Form 6-K, a Report of Foreign Private Issuer.
Who is the registrant?
The registrant is CAMTEK LTD.
What is the reporting period for this Form 6-K?
The filing is for the month of August 2024.
Does Camtek Ltd. file annual reports under Form 20-F?
Yes, the filing indicates with a checkmark that the registrant files annual reports under cover of Form 20-F.
Where is Camtek Ltd. located?
Camtek Ltd.'s principal corporate offices are located in Migdal Haemek, Israel.
Filing Stats: 4,963 words · 20 min read · ~17 pages · Grade level 12.4 · Accepted 2024-08-15 10:38:33
Filing Documents
- zk2431860.htm (6-K) — 735KB
- image00002.jpg (GRAPHIC) — 8KB
- 0001178913-24-002649.txt ( ) — 747KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the Month of August 2024 CAMTEK LTD. (Translation of Registrant's Name into English) Ramat Gavriel Industrial Zone P.O. Box 544 Migdal Haemek 23150 ISRAEL (Address of Principal Corporate Offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities and Exchange Act of 1934. Yes No SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. This Form 6-K, including all exhibits hereto, is hereby incorporated by reference into all effective registration statements filed by the registrant under the Securities Act of 1933. CAMTEK LTD. (Registrant) By: /s/ Moshe Eisenberg ________________________ Moshe Eisenberg, Chief Financial Officer Dated: August 15, 2024 CAMTEK LTD ___________________________________________ NOTICE OF AN ANNUAL GENERAL MEETING OF SHAREHOLDERS ___________________________________________ TO BE HELD SEPTEMBER 25, 2024 Dear Shareholder, You are cordially invited to attend, and notice is hereby given of, an Annual General Meeting of Shareholders of Camtek Ltd (the " Company "), to be held at the Company's offices at Ramat Gavriel Industrial Zone, Migdal Ha'Emek, Israel (the " Company's Offices "), on Wednesday, September 25, 2024, at 4:00 PM (Israel time) (the " Meeting ") for the following purposes: A) To re-elect each of Messrs. Rafi Amit, Yotam Stern, Moty Ben-Arie, I-Shih Tseng, Leo Huang and Ms. Orit Stav to serve as members of the Board of Directors of the Company; B) To re-elect each of Ms. Yael Andorn and Prof. Yosi Shacham-Diamand to serve on the Board of Directors of the Company as external directors, for a third three-year term; C) To approve certain amendments to the Company's Compensation Policy; D) To approve the grant of equity awards to each of the Company's non-controlling directors, subject to their respective re-election for service; E) To approve compensation to the Company's Chief Executive Officer; F) To approve an amendment to the Company's Articles of Association; and G) To approve the re-appointment of Somekh Chaikin, a member firm of KPMG International, as the Company's independent auditor for the fiscal year ending December 31, 2024, for the year commencing January 1, 2025 and until the next annual general meeting of shareholders, and to authorize the Company's Board of Directors, upon the recommendation of the Audit Committee, to set the annual compensation of the independent auditor in accordance with the volume and nature of its services. At the Meeting, shareholders will also have an opportunity to discuss the independent auditor's report and the audited consolidated financial statements of the Company for the year ended December 31, 2023; this item will not involve a vote of the shareholders. Should changes be made to any item on the agenda for the Meeting after the publication of this proxy statement, the Company will communicate the changes to its shareholders through the publication of a press release, a copy of which will be submitted to the Securities and Exchange Commission (the " SEC ") on a Report on Form 6-K and with the Israeli Securities Authority (the " ISA "). Only shareholders of record at the close of the business day on Tuesday, August 20, 2024, the record date for determining those shareholders eligible to vote at the Meeting, are entitled to vote at the Meeting and at any postponements or adjournments thereof. We intend to hold the Meeting in person and all shareholders are cordially invited to attend the Meeting in person. However, we might hold the Meeting virtually on the above date and time instead of in person. If we determine that a change to a virtual meeting format is advisable or required, an announcement of such change will be submitted to the SEC on a Report on Form 6-K and with the ISA, as promptly as practicable. Whether or not you plan to attend the Meeting in person, you are urged to promptly complete, date and sign the enclosed proxy and to mail it in the enclosed envelope, which requires no postage if mailed in the United States. A beneficial shareholder who holds his, her or its shares through a member of the Tel-Aviv Stock Exchange Ltd. (" TASE "), and intends to vote his, her or its shares by proxy, should deliver or mail (via registered mail) his, her or its completed proxy to the Company's Offices, Attention: Chief Financial Officer, together